Representatives from Luxfer Gas Cylinders will join doctors, clinicians, patients and experts from all areas of long-term oxygen therapy (LTOT) at the sixth Oxygen Consensus Conference.
The conference, which is held 25-28 August in Denver, Colorado, is focused on problems confronting LTOT patients and development of action plans for addressing the problems.
The five previous oxygen consensus conferences, which took place between 1986 and 2000, have stimulated development of oxygen standards and other improvements for oxygen therapy.
An estimated 14 to 16 million Americans suffer from chronic obstructive pulmonary disease (COPD) and approximately ten percent require home oxygen therapy to treat chronically low oxygen levels in the blood. Lack of proper oxygen intake can result in diminished brain function and, over time, can cause many of the same symptoms as Alzheimer’s disease, including confusion and forgetfulness.
Obstacles to effective treatment of COPD include reductions in Medicare coverage of oxygen for LTOT, outdated research and lack of doctor and patient education.
Luxfer conference participants France Meder and Vicky Butler hope to help eliminate these obstacles by contributing towards creating greater awareness among consumers and the medical community about the complex nature and important benefits of long-term oxygen therapy, the technology options currently available and being developed.
The Luxfer representatives also hope to promote earlier testing of older Americans for low blood-oxygen and achievement of better federal and state policies to strengthen patient access to oxygen through Medicare and Medicaid.